Comparison in Short-Term Safety and Efficacy between New-Generation WATCHMAN FLX and Conventional WATCHMAN 2.5 for Percutaneous Left Atrial Appendage Closure.
Nobuyuki FukudaTeruhiko ImamuraShuhei TanakaNaoya KataokaRyuichi UshijimaHiroshi UenoKoichiro KinugawaPublished in: Journal of clinical medicine (2022)
Percutaneous left atrial appendage closure using new-generation WATCHMAN FLX seemed to be as safe and effective as conventional WATCHMAN 2.5 during the short-term observational period.